- Patients must have received anticoagulating agent for at least 6 months for any new DVT/PE or other evidence of venous thromboembolism. Patients with evidence of arterial clot must be stable for 3 months on anti-platelet therapy or other anticoagulation as deemed necessary by the investigator.